94-13494. Announcement of a Cooperative Agreement to the World Health Organization  

  • [Federal Register Volume 59, Number 106 (Friday, June 3, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-13494]
    
    
    [[Page Unknown]]
    
    [Federal Register: June 3, 1994]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    [CDC-464]
    
     
    
    Announcement of a Cooperative Agreement to the World Health 
    Organization
    
    Summary
    
        The Centers for Disease Control and Prevention (CDC), announces the 
    availability of funds for fiscal year (FY) 1994 for a sole source 
    cooperative agreement with the World Health Organization (WHO) to 
    conduct polio surveillance, provide technical assistance in developing 
    a laboratory network, provide programmatic assistance to carry out 
    operational and applied research, and to provide oral polio vaccine for 
    supplemental immunization activities for the global initiative to 
    eradicate polio by the year 2000. Approximately $1.2 to $1.6 million 
    will be available in FY 1994 to support this project. It is expected 
    the award will begin on July 1, 1994, for a 12-month budget period 
    within a 3-year project period. The funding estimate is subject to 
    change. Continuation awards within the project period will be made on 
    the basis of satisfactory progress and availability of funds.
        The purpose of this cooperative agreement is to support the polio 
    eradication initiative by providing technical, laboratory, programmatic 
    consultants, operational and applied research, oral polio vaccine, and 
    other services, as needed, to the governments of polio endemic 
    countries. Specific activities should be in the areas of polio 
    surveillance to define and assess the polio endemic countries, 
    including surveillance for acute flaccid paralysis, development of a 
    laboratory network for poliovirus isolation in developing countries, 
    and assistance to foreign governments in planning and implementing 
    national immunization days and other polio eradication activities.
        CDC will collaborate by providing (1) technical assistance to WHO 
    in support of activities implemented under this agreement; (2) 
    programmatic support to national governments for planning, 
    implementing, and evaluating polio eradication activities; (3) 
    technical training, support, and consultation to expert staff hired by 
    WHO to assist in the polio eradication initiative; (4) expertise for 
    the surveillance to assess, define, and prioritize the assistance needs 
    of polio endemic countries and assist in the development of a 
    laboratory network for poliovirus isolation in developing countries; 
    and (5) other technical assistance in support of this project, as 
    needed.
        The Public Health Service (PHS) is committed to achieving the 
    health promotion and disease prevention objectives of Healthy People 
    2000, a PHS-led national activity to reduce morbidity and mortality and 
    improve the quality of life. This announcement is related to the 
    priority area of Immunization and Infectious Diseases. (For ordering a 
    copy of ``Healthy People 2000,'' see the Section ``Where To Obtain 
    Additional Information.'')
    
    Authority
    
        This program is authorized under sections 301 and 307 of the Public 
    Health Service Act, as amended, 42 U.S.C. 241 and 242l, and section 104 
    of the Foreign Assistance Act of 1961, 22 U.S.C. 2151b.
    
    Smoke-Free Workplace
    
        The Public Health Service strongly encourages all grant recipients 
    to provide a smoke-free workplace and promote the non-use of all 
    tobacco products. This is consistent with the PHS mission of promoting 
    the protection and advancement of an individual's physical and mental 
    health.
    
    Eligible Applicant
    
        Eligibility for assistance is limited to the World Health 
    Organization for this project. No other applications are solicited. The 
    program announcement and application kit have been sent to WHO.
        WHO is the most appropriate and qualified agency to conduct the 
    activities under this cooperative agreement because:
        A. WHO has the lead responsibility among the United Nations 
    organizations for implementing the World Health Assembly resolution of 
    1988 calling for the global eradication of polio by the year 2000. WHO 
    is the only organization with a worldwide mandate for the control and 
    prevention of vaccine preventable diseases.
        B. The proposed program is strongly supportive of and directly 
    related to the achievement of WHO and CDC/National Immunization Program 
    objectives for the control and prevention of vaccine preventable 
    diseases.
        C. WHO, together with UNICEF, the Pan American Health Organization, 
    Rotary International, and CDC, is a member of the Polio Eradication 
    Network, an organization formed to increase support and visibility for 
    the polio eradication initiative.
    
    Executive Order 12372 Review
    
        The application is not subject to review under Executive Order 
    12372, Intergovernmental Review of Federal Programs.
    
    Public Health System Reporting Requirements
    
        This program is not subject to the Public Health System Reporting 
    Requirements.
    
    Catalog of Federal Domestic Assistance Number
    
        The Catalog of Federal Domestic Assistance Number for this program 
    is 93.185, Immunization Research, Demonstration, Public Information, 
    and Education, Training, and Clinical Skills Improvement Projects.
    
    Other Requirements
    
    Human Subjects
    
        If any of the proposed projects involve research on human subjects, 
    the applicant must comply with the Department of Health and Human 
    Services Regulations, 45 CFR Part 46, regarding the protection of human 
    subjects. Assurance must be provided to demonstrate that the project 
    will be subject to initial and continuing review by an appropriate 
    institutional review committee. The applicant will be responsible for 
    providing assurance in accordance with the appropriate guidelines and 
    form provided in the application kit.
    
    Where to Obtain Additional Information
    
        If you are interested in obtaining additional information regarding 
    this project, please refer to Announcement 464 and contact Carole J. 
    Tully, Grants Management Specialist, Grants Management Branch, 
    Procurement and Grants Office, Centers for Disease Control and 
    Prevention (CDC), 255 East Paces Ferry Road, NE., room 300, Mailstop E-
    09, Atlanta, GA 30305, telephone (404) 842-6880.
        A copy of ``Healthy People 2000'' (Full Report, Stock No. 017-001-
    00474-0) or ``Healthy People 2000'' (Summary Report, Stock No. 017-001-
    00473-1) referenced in the ``Summary'' may be obtained through the 
    Superintendent of Documents, Government Printing Office, Washington, DC 
    20402-9325, telephone (202) 783-3238.
    
        Dated: May 27, 1994.
    Ladene H. Newton,
    Acting Associate Director for Management and Operations, Centers for 
    Disease Control and Prevention (CDC).
    [FR Doc. 94-13494 Filed 6-2-94; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
06/03/1994
Department:
Health and Human Services Department
Entry Type:
Uncategorized Document
Document Number:
94-13494
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: June 3, 1994, CDC-464